DrugPatentWatch Database Preview

Details for Patent: 8,486,973

Which drugs does patent 8,486,973 protect, and when does it expire?

Patent 8,486,973 protects SUBSYS and is included in one NDA.

This patent has four patent family members in four countries.

Summary for Patent: 8,486,973

Title:	Sublingual fentanyl spray
Abstract:	The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable salt thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.
Inventor(s):	Kottayil; S. George (Phoenix, AZ), Goskonda; Venkat R. (Gurnee, IL), Zhu; Zhongyuan (Vernon Hills, IL), Kattookaran; Linet (Des Plaines, IL), Parikh; Neha (Chicago, IL)
Assignee:	Insys Therapeutics, Inc. (Phoenix, AZ)
Application Number:	12/221,333
Patent Claim Types: see list of patent claims	Use; Formulation; Composition; Delivery; Device;

Drugs Protected by US Patent 8,486,973

Glossary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Insys Dev Co Inc	SUBSYS	fentanyl	SPRAY;SUBLINGUAL	202788-001	Jan 4, 2012		RX	Yes	No	➤ Sign Up	➤ Sign Up				TREATMENT OF PAIN	➤ Sign Up
Insys Dev Co Inc	SUBSYS	fentanyl	SPRAY;SUBLINGUAL	202788-002	Jan 4, 2012		RX	Yes	No	➤ Sign Up	➤ Sign Up				TREATMENT OF PAIN	➤ Sign Up
Insys Dev Co Inc	SUBSYS	fentanyl	SPRAY;SUBLINGUAL	202788-003	Jan 4, 2012		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				TREATMENT OF PAIN	➤ Sign Up
Insys Dev Co Inc	SUBSYS	fentanyl	SPRAY;SUBLINGUAL	202788-004	Jan 4, 2012		RX	Yes	No	➤ Sign Up	➤ Sign Up				TREATMENT OF PAIN	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted

Non-Orange Book US Patents Family Members for Patent 8,486,973

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Patent No.	Title	Estimated Patent Expiration
9,642,844	Sublingual fentanyl spray	➤ Sign Up
8,835,459	Sublingual fentanyl spray	➤ Sign Up
9,241,935	Sublingual fentanyl spray	➤ Sign Up
Patent No.	Title	Estimated Patent Expiration

International Patents Family Members for US Patent 8,486,973

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2008282743	➤ Sign Up
Canada	2698749	➤ Sign Up
European Patent Office	2180844	➤ Sign Up
World Intellectual Property Organization (WIPO)	2009017837	➤ Sign Up
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Summary for Patent: 8,486,973

For more information try a trial or see the plans and pricing